QA: Lixte Biotechnology Holdings INC in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001335105_2013_Lixte_Biotechnology_Holdings_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001335105, Lixte Biotechnology Holdings INC

  xvar xval
0 AssetsCurrent 1,753,010
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 261,152
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,093,614
9 ResearchAndDevelopmentExpense 1,012,144
10 remainder_Expenses 1,473,616
11 remainder_Revenues 0
12 remainder_NetIncome 8.00
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 1,753,010
1 Liabilities 261,152
2 Expenses 3,579,374
3 Revenues 0
4 StockholdersEquity 1,491,858
5 NetIncome -3,579,366
6 ComprehensiveNetIncome -3,579,366
7 BaseVar 2,796,772
8 EconomicCapitalRatiobeforeLimitedLiability -0.325
9 EconomicCapitalRatio 1.40

Edgar->Model Mapping

Feature Distribution